QCG
CDLX icon

Quadrant Capital Group’s Cardlytics CDLX Stock Holding History

Quadrant Capital Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6
Closed -$477 – 2745
2024
Q2 		$477 Hold
6
– – ﹤0.01% 2632
2024
Q1 		$841 Hold
6
– – ﹤0.01% 2606
2023
Q4 		$535 Sell
6
-3
-33% -$305 ﹤0.01% 2610
2023
Q3 		$1.44K Hold
9
– – ﹤0.01% 2451
2023
Q2 		$550 Hold
9
– – ﹤0.01% 2559
2023
Q1 		$296 Hold
9
– – ﹤0.01% 2651
2022
Q4 		$503 Buy
9
+1
+13% +$62 ﹤0.01% 2621
2022
Q3 		$1K Buy
8
+7
+700% +$996 ﹤0.01% 2483
2022
Q2 		$0 Hold
1
– – ﹤0.01% 2552
2022
Q1 		$0 Hold
1
– – ﹤0.01% 2511
2021
Q4 		$0 Buy
+1
New +$764 ﹤0.01% 2526
2021
Q3 		– Hold
0
– – – 2517
2021
Q2 		– Hold
0
– – – 2422

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Quadrant Capital Group's CDLX Position: Q3 2024 in Review

Quadrant Capital Group sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 6 shares — an estimated $477 sold.

Quadrant Capital Group first reported a position in CDLX in Q4 2021 and held it in 11 quarters. The position peaked at $1.44K in Q3 2023. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • Quadrant Capital Group reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • Quadrant Capital Group sold 6 Cardlytics shares in Q3 2024, an estimated $477.
  • Quadrant Capital Group first reported a position in Cardlytics in Q4 2021 and held it in 11 quarters.
  • Quadrant Capital Group's Cardlytics position peaked at $1.44K in Q3 2023.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on Quadrant Capital Group's 13F filing for Q3 2024, filed 12 Nov 2024.